Clarivate Plc (DE:16A)
NYSE:16A
16A Stock Chart & Stats
€2.29
€0.10(2.10%)
At close: 4:00 PM EST
€2.29
€0.10(2.10%)
Day’s Range― - ―
52-Week Range€1.45 - €4.12
Previous CloseN/A
Volume0.00
Average Volume (3M)148.00
Market Cap
€1.32B
Enterprise Value€5.72B
Total Cash (Recent Filing)€232.30M
Total Debt (Recent Filing)€4.33B
Price to Earnings (P/E)―
Beta1.27
Next Earnings
Aug 11, 2026EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding639,216,500
10 Day Avg. Volume444
30 Day Avg. Volume148
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)0.46
Price to Sales (P/S)0.92
P/FCF Ratio6.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.10Price Target Upside35.44% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)0.63
Revenue Forecast (FY)€2.01B
Bulls Say, Bears Say
Bulls Say
Business StrategyCLVT has restructured its business model to focus on recurring revenue streams, which is expected to provide more stability in revenue.
Financial GuidanceManagement raised full-year revenue guidance due to improved organic growth outlook and favorable FX rates.
Revenue PerformanceClarivate's third-quarter revenue exceeded estimates by $53 million, driven by higher-than-expected transactional revenues.
Bears Say
Growth RisksThe largest risks to CLVT's growth prospect include AI disintermediation, high leverage, and execution on its value creation plan.
ProfitabilityAdjusted EBITDA margin fell short of the model by 140 basis points.
Revenue StabilityRecurring revenue fell short, coming in 70 basis points below the model.
Clarivate News
16A FAQ
What was Clarivate Plc’s price range in the past 12 months?
Clarivate Plc lowest stock price was €1.45 and its highest was €4.12 in the past 12 months.
What is Clarivate Plc’s market cap?
Clarivate Plc’s market cap is €1.32B.
When is Clarivate Plc’s upcoming earnings report date?
Clarivate Plc’s upcoming earnings report date is Aug 11, 2026 which is in 62 days.
How were Clarivate Plc’s earnings last quarter?
Clarivate Plc released its earnings results on Apr 29, 2026. The company reported €0.154 earnings per share for the quarter, beating the consensus estimate of €0.124 by €0.03.
Is Clarivate Plc overvalued?
According to Wall Street analysts Clarivate Plc’s price is currently Undervalued.
Does Clarivate Plc pay dividends?
Clarivate Plc does not currently pay dividends.
What is Clarivate Plc’s EPS estimate?
Clarivate Plc’s EPS estimate is 0.15.
How many shares outstanding does Clarivate Plc have?
Clarivate Plc has 639,216,500 shares outstanding.
What happened to Clarivate Plc’s price movement after its last earnings report?
Clarivate Plc reported an EPS of €0.154 in its last earnings report, beating expectations of €0.124. Following the earnings report the stock price went up 7.156%.
Which hedge fund is a major shareholder of Clarivate Plc?
Currently, no hedge funds are holding shares in DE:16A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clarivate Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€3.10 (35.44% Upside)
€3.10 (35.44% Upside)
Blogger Sentiment
Bullish
DE:16A Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.52%
12-Months-Change
Fundamentals
Return on Equity
-2.81%
Trailing 12-Months
Asset Growth
-4.92%
Trailing 12-Months
Company Description
Clarivate Plc
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
16A Company Deck
16A Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mix of constructive operational and financial progress alongside material near-term headwinds. Highlights include margin expansion (adjusted EBITDA margin up ~200 bps to 41%), improved subscription mix (roughly 88%–89%), strengthened renewal discipline (+100 bps), AI-driven product adoption and efficiency gains, debt reduction actions and a reaffirmed full-year guidance with anticipated free cash flow growth to ~$400M. Offsetting these positives are modest organic growth rates (organic ACV 1.6%), Q1 free cash flow down $31M, transactional revenue softness, planned revenue reductions from disposals (~$100–130M), first-half timing pressure in patent renewals, and a potentially large cash tax increase disclosed in the call, which introduces meaningful near-term cash risk and uncertainty. Overall, the improvement trajectory and margin/cash generation outlook are encouraging, but the modest growth rates and several notable risks keep the picture balanced.View all DE:16A earnings summaries16A Stock 12 Month Forecast
Average Price Target
€3.10
▲(35.44% Upside)
Technical Analysis
Options Prices
Currently, No data available
---